explore -WSS

explore

author：fashion 2025-10-02 08:32:29 - browse：5811

Miniature people figurines standing in a group looking down. -- health tech coverage from STAT — Adobe

In less than two years, digital health’s high-flying class of public debuts have landed with a resounding thud.

Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt. Twelve companies have lost more than 90% of their initial value, including Bright Health Group, Cue Health, and Better Therapeutics. And dangerously low reserves have inspired desperate moves to slash costs, drum up liquidity, and find buyers.

Most recently, the bankruptcy of digital primary care company Babylon Health has drawn attention to the plight of newly-public health tech companies, and how the froth of dealmaking at the height of the pandemic led to overblown valuations. Before its debut in June 2021, Babylon was valued at $4.2 billion; after filing for bankruptcy in August, its U.K. telemedicine business was sold for just over $600,000.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Decaf coffee targeted by food safety group under obscure FDA rule

focus

WSS

Merck drug for rare lung condition set for approval in U.S.

Medicare slashes safety net hospital payments by nearly $1 billion

Florida officials tell state schools to teach AP Psychology 'in its entirety'

FDA approves Sage Therapeutics’ rapid

How I helped Pfizer think through the ethics of Viagra

Abortion pill case raises question: who can sue the FDA?

focus

explore

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

FDA approves Sage Therapeutics’ rapid

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Merck drug for rare lung condition set for approval in U.S.

Virginia high school admissions case could be legal follow

There's no autism epidemic. It's an autism diagnosis epidemic

Apple is now the first public company to be valued at $3 trillion

Will generative AI in health care meet the fate of IBM's Dr. Watson?

In Memoriam: Notable people who died in 2023

Readout LOUD podcast: mifepristone case, GLP

leisure time

Supreme Court mifepristone arguments center on docs' right to sue

'Null' research findings aren't empty of meaning. Let's publish them

FDA approves Sage Therapeutics’ rapid

Florida officials tell state schools to teach AP Psychology 'in its entirety'

'Null' research findings aren't empty of meaning. Let's publish them

The Readout: Lenmeldy, GLP

entertainment

focus

entertainment

knowledge